Somatec Pharmaceuticals

What Somatec Pharmaceuticals does

Somatec Pharmaceuticals Ltd. (dba: SOMATEC) is a Bangladesh-based private limited pharmaceutical manufacturer established in 1991 that began manufacturing and marketing products in 1994. The company manufactures and markets over 100 pharmaceutical products spanning multiple therapeutic classes, including antifungals (Trivorin/Voriconazole), antihistamines (Blextin/Bilastine), proton pump inhibitors (XLan/Dexlansoprazole), folate supplements (Natfol), and calcium/vitamin D supplements (Coralmet D), with 100 unique research projects supporting its product development pipeline. Operations are anchored by WHO Good Manufacturing Practice (GMP) certification, validating compliance with international quality standards, and the company maintains over 1,200 employees across manufacturing and distribution functions.

The company operates a sales-led go-to-market model, deploying field-based medical representatives to engage healthcare providers (doctors, hospitals, clinics) and reaching retail and wholesale pharmacies through 19+ distribution networks covering Bangladesh. Leadership is concentrated under Managing Director Syed Rafiqur Rahim, a Dhaka University Pharmacy Masters graduate who has headed the company since 1994. Customer-facing infrastructure includes a doctors' section, pharmacovigilance, and patient-facing pages on the company website.

Somatec generates revenue through one-time product sales of generics and branded pharmaceutical products distributed via prescription and OTC channels across Bangladesh. Pricing is not publicly disclosed. The company has no disclosed institutional investors, parent company, funding rounds, or M&A activity, and operates as a founder-led private entity focused on the South Asia (predominantly Bangladesh) market, with a 'Global Presence' page suggesting nascent export exploration.

Name

Somatec Pharmaceuticals

Legal name

SOMATEC PHARMACEUTICALS LTD.

Website

https://somatecpharmabd.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

101–250 employees

Short description

Somatec Pharmaceuticals Ltd. is a Bangladesh-based private pharmaceutical manufacturer founded in 1991, producing 100+ generics and branded medicines across antifungals, antihistamines, PPIs, and supplements. It serves healthcare providers and pharmacy networks domestically via 19+ distribution channels.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Respiratory & Allergy Pharmaceuticals (HLAIAAAH)

akta.pro secondary industry

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ)

Keywords

• Pharmaceutical manufacturing
• Generic medicines
• Antifungal medications
• Antihistamine drugs
• Calcium supplements

Headquarters

HQ city

Dhaka

HQ country

Bangladesh

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Products: Manufacturing and marketing of pharmaceutical products including generics, branded medicines, vitamins and minerals, covering multiple therapeutic classes. Revenue generated through product sales to healthcare providers, pharmacies, and distributors across Bangladesh.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Somatec Pharmaceuticals Ltd. manufactures and markets over 100 pharmaceutical products covering multiple therapeutic classes including antifungals (Voriconazole), antihistamines (Bilastine), proton pump inhibitors (Dexlansoprazole), calcium and vitamin D supplements, and folate-based products. The company operates WHO GMP certified manufacturing facilities and distributes products through 19+ distribution networks across Bangladesh.

Product overview

Somatec Pharmaceuticals Ltd. is a fast-growing pharmaceutical company in Bangladesh established in 1991, manufacturing and marketing over 100 pharmaceutical products. The company operates a portfolio organized by Generic Name, Brand Name, and Therapeutic Class categories. Key products include Trivorin (antifungal), Blextin (antihistamine), Natfol (folate supplement), and Coralmet D (calcium/vitamin D supplement). The company has 19+ distribution networks, over 1200 employees, and maintains WHO Good Manufacturing Practice certification.

Differentiator

Problem solved

Functional benefit

Products and services

• Trivorin Trivorin is an azole antifungal medication containing Voriconazole USP, available in 50mg and 200mg film-coated tablets. Indicated for invasive aspergillosis, candidemia, esophageal candidiasis, and serious infections caused by Scedosporium Apiospermum and Fusarium species.
• Blextin Blextin is an antihistamine medication containing Bilastine INN, available in 10mg and 20mg tablets. Indicated for symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria.
• Natfol Natfol contains Calcium Folinate (Leucovorin Calcium), a metabolite of Folic Acid used in cytotoxic therapy. Indicated for osteosarcoma, to diminish toxicity of impaired Methotrexate elimination, and megaloblastic anemia due to folate deficiency.
• Coralmet D Coralmet D is a calcium and vitamin D supplement tablet containing Calcium Carbonate (Coral source) 500mg and Cholecalciferol (Vitamin D3) 200 IU. Indicated for treatment and prevention of osteoporosis, osteomalacia, rickets, tetany, parathyroid diseases, and calcium deficiency symptoms.
• Pharmaceutical Product Portfolio Over 100 pharmaceutical products including generics, branded medicines, vitamins, and minerals covering multiple therapeutic classes such as antifungals, antihistamines, proton pump inhibitors, calcium supplements, and folate-based medications, manufactured in WHO GMP certified facilities and distributed across Bangladesh.

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators5 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Renata Limited: Diversified Bangladeshi pharmaceutical manufacturer with animal health and human health divisions; competes with Somatec in branded generics and specialty formulations across Bangladesh.
• Healthcare Pharmaceuticals Limited: Bangladeshi pharma manufacturer with a portfolio covering cardiology, oncology, and general therapeutics; competes with Somatec for hospital and specialist prescriptions in Bangladesh.
• Drug International Limited: Bangladesh-based pharmaceutical manufacturer producing generics across multiple therapeutic classes with focus on affordable medicines; directly comparable to Somatec in product mix and distribution model.
• Aristopharma Limited: Bangladesh-based manufacturer producing a wide range of generics including antifungals, antihistamines, and GI products; competes with Somatec across multiple therapeutic categories in the domestic market.
• Square Pharmaceuticals: One of Bangladesh's top pharmaceutical manufacturers with an extensive branded generics portfolio and nationwide distribution. Competes head-to-head with Somatec for healthcare provider prescriptions, pharmacy shelf space, and tender contracts.
• Beximco Pharmaceuticals: Bangladesh's largest exporter of pharmaceuticals and a leading domestic manufacturer with a broad generics and specialty portfolio. Direct competitor to Somatec in the Bangladeshi market across multiple therapeutic classes including antihistamines, antifungals, and PPIs.
• Eskayef Pharmaceuticals: Bangladeshi pharma manufacturer with strong generics portfolio and export presence; competes directly with Somatec for domestic prescriptions and increasingly for international tenders.
• ACI Limited (Pharmaceuticals): Bangladesh conglomerate with a sizable pharma division manufacturing branded generics and OTC products. Competes with Somatec in similar therapeutic categories and through overlapping pharmacy distribution channels.
• Incepta Pharmaceuticals: Bangladesh's second-largest pharma company by revenue, with a wide therapeutic range and a strong R&D pipeline that regularly introduces latest-molecule generics. Direct competitor to Somatec, particularly in the differentiated generics space.

Broad incumbents

• Cipla Limited: Indian multinational pharmaceutical giant with a major presence across emerging markets including South Asia. While not a Bangladesh-headquartered peer, it competes in similar therapeutic categories and serves as a benchmark for scale and export capability.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Somatecpharma
• LinkedInlinkedin.com/company/somatec-pharmaceuticals-ltd

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Somatec Pharmaceuticals